ACNB Corp (ACNB) director reports 213.6955-share stock award in insider filing
Rhea-AI Filing Summary
ACNB Corp disclosed that director John M. Polli acquired 213.6955 shares of ACNB Corporation common stock on 12/15/2025 at $52.645 per share. The transaction is coded as an acquisition and represents stock received as compensation for his service as a director under a director compensation plan, with a deemed execution date of 12/16/2025 determined under SEC Rule 16a-3.
After this transaction, Polli beneficially owns 35,556.4581 shares of ACNB common stock in direct form. This total includes shares purchased on the same transaction date through automatic reinvestment of dividends under the ACNB Corporation Dividend Reinvestment and Stock Purchase Plan, which are described as exempt from the reporting requirements of Section 16 of the Securities Exchange Act of 1934.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did ACNB (ACNB) report in this Form 4?
ACNB Corp reported that director John M. Polli acquired 213.6955 shares of ACNB Corporation common stock on 12/15/2025, coded as an acquisition.
At what price did the ACNB Corp director acquire the reported shares?
The 213.6955 shares of ACNB Corporation common stock were acquired at a price of $52.645 per share.
How many ACNB Corp shares does John M. Polli own after this transaction?
Following the reported transaction, John M. Polli beneficially owns 35,556.4581 shares of ACNB Corporation common stock in direct ownership.
How did the ACNB (ACNB) director receive the reported shares?
The filing states that the shares represent stock received as compensation for service as a director pursuant to a director compensation plan.
What is the role of the dividend reinvestment plan in Polli’s ACNB holdings?
The total of 35,556.4581 shares includes common stock purchased on the same transaction date through automatic reinvestment of dividends under the ACNB Corporation Dividend Reinvestment and Stock Purchase Plan, which is described as exempt from Section 16 reporting.
What special date treatment is disclosed for this ACNB insider transaction?
While the transaction date is 12/15/2025, the filing notes a deemed execution date of 12/16/2025, determined in accordance with SEC Rule 16a-3(g)(2) and (g)(4).